Bedfont expands its reach in the Middle East by obtaining registration for its Gastro+ Gastrolyzer

MAIDSTONE, U.K. - Feb. 25, 2021 - PRLog -- Leaders in breath analysis medical devices, Bedfont Scientific Ltd., announced that it has successfully registered its Gastro⁺™ Gastrolyzer® for sale in the United Arab Emirates.

A big part of UAE culture, food is often used to celebrate and bring people together, however according to the Food Allergy Research & Education, "as many as 15 million people suffer food intolerances"¹, and as many as 11%  are lactose intolerant according to a report published by the US Census Bureau International Data Base².

A portable hydrogen monitor, the Gastro⁺™ works by measuring the amount of hydrogen in a patient's breath caused by the breakdown of food in the gut. This aids HCP's in investigating if a patient has any sugar-related food intolerances, such as lactose intolerance, and it can also be used to help detect other gastrointestinal disorders such as SIBO and IBS.  Unlike more conventional methods which can take up to two weeks to diagnose, the simple breath test does not require a blood sample and provides instant results.

Jason Smith, Managing Director at Bedfont, comments, "Our Regulatory Affairs department has been working hard on this registration for 9 months, and we're over the moon to be able to say we can now sell the Gastro⁺™ into the UAE. It's going to help a lot of people improve their quality of life, and we looking forward to working more closely with our distributor there, Al Zahrawi Medical Supplies LLC. "